Yong-Liang Che

Dr. Yong-Liang Che


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2023 in Viruses
Verified
Journal Article
Open access
PDF file
QCQiu-Yong CHEN
Qiu-Yong CHEN
ZSZhi-Hua Sun
Zhi-Hua Sun
YCYong-Liang Che
Yong-Liang Che
RCRu-Jing Chen
Ru-Jing Chen
XWXuemin Wu
Xuemin Wu
AZAnd Lun-jiang ZHOU
And Lun-jiang ZHOU
Porcine sapelovirus (PSV) is a ubiquitous virus in farmed pigs that is associated with SMEDI syndrome, polioencephalomyelitis, and diarrhea. However, there are few reports on the prevalence and molecular characterization of PSV in Fujian Province, Southern China. In this study, the prevalence of PSV and a poetical combinative strain PSV2020 were characterized using real-time PCR, sequencing, and bioinformatics analysis. As a result, an overall sample prevalence of 30.8% was detected in 260 fecal samples, and a farm prevalence of 76.7% was observed in 30 Fujian pig farms, from 2020 to 2022. Noteably, a high rate of PSV was found in sucking pigs. Bioinformatics analysis showed that the full-length genome of PSV2020 was 7550 bp, and the genetic evolution of its ORF region was closest to the G1 subgroup, which was isolated from Asia and America; the similarity of nucleotides and amino acids to other PSVs was 59.5~88.7% and 51.7~97.0%, respectively. However, VP1 genetic evolution analysis showed a distinct phylogenetic topology from the ORF region; PSV2020 VP1 was closer to the DIAPD5469-10 strain isolated from Italy than strains isolated from Asia and America, which comprise the G1 subgroup based on the ORF region. Amino acid discrepancy analysis illustrated that the PSV2020 VP1 gene inserted twelve additional nucleotides, corresponding to four additional amino acids (STAE) at positions 898–902 AAs. Moreover, a potential recombination signal was observed in the 2A coding region, near the 3′ end of VP1, owing to recombination analysis. Additionally, 3D genetic evolutionary analysis showed that all reference strains demonstrated, to some degree, regional conservation. These results suggested that PSV was highly prevalent in Fujian pig farms, and PSV2020, a PSV-1 genotype strain, showed gene diversity and recombination in evolutionary progress. This study also laid a scientific foundation for the investigation of PSV epidemiology, molecular genetic characteristics, and vaccine development.

21 September 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
QCQiu-Yong CHEN
Qiu-Yong CHEN
XWXuemin Wu
Xuemin Wu
YCYong-Liang Che
Yong-Liang Che
RCRu-Jing Chen
Ru-Jing Chen
BHBo Hou
Bo Hou
AZAnd Lun-jiang ZHOU
And Lun-jiang ZHOU
An emerging pseudorabies virus (PRV) variant has been reported on Bartha-K61-vaccinated farms since 2011, causing great economic losses to China’s swine-feeding industry. In this study, two vaccines, FJ-2012ΔgE/gI-GEL02 and FJ-2012ΔgE/gI-206VG, were administered to piglets for immune efficacy investigation. Humoral immunity response, clinical signs, survival rate, tissue viral load, and pathology were assessed in piglets. The results showed that both vaccines were effective against the PRV FJ-2012 challenge, the piglets all survived while developing a high level of gB-specific antibody and neutralizing antibody, the virus load in tissue was alleviated, and no clinical PR signs or pathological lesions were displayed. In the unimmunized challenged group, typical clinical signs of pseudorabies were observed, and the piglets all died at 7 days post-challenge. Compared with commercial vaccines, the Bartha-K61 vaccine group could not provide full protection, which might be due to a lower vaccine dose; the inactivated vaccine vPRV* group piglets survived, displaying mild clinical signs. The asterisk denotes inactivation. These results indicate that FJ-2012ΔgE/gI-GEL02 and FJ-2012ΔgE/gI-206VG were effective and could be promising vaccines to control or eradicate the new PRV epidemic in China.

20 September 2024 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
JJJinxiu Jiang
Jinxiu Jiang
YLYusheng Lin
Yusheng Lin
JZJingpeng Zhang
Jingpeng Zhang
WLWeiwei Liu
Weiwei Liu
QHQilin Hu
Qilin Hu
YCYong-Liang Che
Yong-Liang Che
Mycoplasmal pneumonia of sheep and goats (MPSG) is an important infectious disease that threatens sheep and goat production worldwide, and Mycoplasma ovipneumoniae (Movi) is one of the major aetiological agents causing MPSG. The aim of this study was to investigate the immunological activity of the Hsp70‒P113 fusion protein derived from Movi and to develop a serological assay for the detection of Movi. This study involved codon optimization of the dominant antigenic regions of Movi heat shock protein 70 (Hsp70) and adhesin P113. Afterwards, the optimized sequences were inserted into the prokaryotic expression vector pET-30a( +) through tandem linking with the aid of a linker. Once a positive recombinant plasmid (pET-30a-rHsp70-P113) was successfully generated, the expression conditions were further refined. The resulting double gene fusion target protein (rHsp70‒P113) was subsequently purified using ProteinIso® Ni–NTA resin, and the reactivity of the protein was confirmed via SDS‒PAGE and Western blot analysis. An indirect enzyme-linked immunosorbent assay (i-ELISA) technique was developed to detect Movi utilizing the fusion protein as the coating antigen. The specificity, sensitivity, and reproducibility of all methods were assessed after each reaction parameter was optimized. The resulting rHsp70-P113 protein had a molecular weight of approximately 51 kDa and was predominantly expressed in the supernatant. Western blot analysis demonstrated its favourable reactivity. The optimal parameters for the i-ELISA technique were as follows: the rHsp70-P113 protein was encapsulated at a concentration of 5 μg/mL; the serum was diluted at a ratio of 1:50; the HRP-labelled donkey anti-goat IgG was diluted at a ratio of 1:6,000. The results of the cross-reactivity assays revealed that the i-ELISA was not cross-reactive with other goat-positive sera against Mycoplasma mycodies subsp. capri (Mmc), Mycoplasma capricolum subsp. capripneumoniae (Mccp), Mycoplasma arginini (Marg), orf virus (ORFV) or enzootic nasal tumour virus of goats (ENTV-2). The sensitivity of this method is high, with a maximum dilution of up to 1:640. The results of the intra- and inter-batch replication tests revealed that the coefficients of variation were both less than 10%, indicating excellent reproducibility. The analysis of 108 clinical serum samples via i-ELISA and indirect haemagglutination techniques yielded significant findings. Among these samples, 43 displayed positive results, whereas 65 presented negative results, resulting in a positivity rate of 39.8% for the i-ELISA method. In contrast, the indirect haemagglutination technique identified 20 positive samples and 88 negative samples, resulting in a positivity rate of 18.5%. Moreover, a comparison between the two methods revealed a conformity rate of 78.7%. The results obtained in this study lay the groundwork for advancements in the use of an Movi antibody detection kit, epidemiological inquiry, and subunit vaccines.

13 May 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
RWRen-Jie Wu
Ren-Jie Wu
YCYong-Liang Che
Yong-Liang Che
LWLong-bai WANG
Long-bai WANG
QCQiu-Yong CHEN
Qiu-Yong CHEN
BHBing He
Bing He
AZAnd Lun-jiang ZHOU
And Lun-jiang ZHOU
Background/Objectives: The emergence and transmission of the tigecycline resistance efflux pump gene cluster tmexCD-toprJ among humans, animals and the environment have posed a serious threat to public health. The objective of this study was to characterize Pseudomonas strains carrying multiple copies of tmexC6D6-toprJ1b from a pig farm and illustrate the genetic context of tmexC6D6-toprJ1b in the NCBI database. Methods: The characterization of Pseudomonas strains FJFQ21PNM23 and FJFQ21PNM24 was determined by antimicrobial susceptibility testing, whole-genome sequencing, and RT-qPCR. Results: The tmexCD-toprJ-positive P. mendocina strains FJFQ21PNM23 and FJFQ21PNM24 were isolated from nasal swabs in a pig farm. Sequence analysis showed that the two P. mendocina strains harbored multiple antimicrobial resistance genes, including tigecycline resistance gene tmexC6D6-toprJ1b. WGS analysis indicated that tmexC6D6-toprJ1b gene was located on a classical transferable module (int1-int2-hp1-hp2-tnfxB-tmexCD-toprJ) and a multiresistance region in FJFQ21PNM24 and FJFQ21PNM23, respectively. Further analysis revealed that 39 additional tmexC6D6-toprJ1b genes in the NCBI database were all identified in Pseudomonas spp., and the genetic features of tmexC6D6-toprJ1b were summarized into three distinct structures. Conclusions: This study is the first to identify and report the tigecycline resistance gene tmexCD-toprJ in a swine farm. Our findings summarize the three structures in the genetic context of tmexC6D6-toprJ1b and reveal that Pseudomonas serves as the only known reservoir of tmexC6D6-toprJ1b.

13 April 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
JZJingpeng Zhang
Jingpeng Zhang
DZDingding Zhang
Dingding Zhang
JJJinxiu Jiang
Jinxiu Jiang
YLYusheng Lin
Yusheng Lin
Chunhe WanChunhe Wan
Chunhe Wan
YCYong-Liang Che
Yong-Liang Che
C. pseudotuberculosis is a Gram-positive pathogenic bacterium that infects various animals, causing diseases such as caseous lymphadenitis, leading to significant economic losses in the livestock industry and posing zoonotic risks. This study targeted the conserved gyrA gene fragment of this bacterium, designed specific primers, optimized the reaction system and conditions, and established a high-resolution melting curve (HRM) detection method with potential utility for preliminary molecular screening. Validation showed that this method exhibits strong specificity, producing specific amplification only for the target biovars. The melting temperatures (Tm values) for the two biovars were 86.16 ± 0.05 °C and 86.92 ± 0.05 °C, respectively, allowing clear differentiation. It demonstrated high sensitivity, with minimum detection limits of 28 copies/μL and 25 copies/μL for standard plasmids of the ovis and equi biovars, respectively. The method also showed good reproducibility, with intra- and inter-batch coefficients of variation both below 1.0%. Applied to 133 clinical nasal swab samples from goats in Fujian Province, the method detected a positivity rate of 19.5% and indicates that a biovar equi-like gene fragment was detected in goat nasal swabs from Fujian Province via molecular screening. The HRM method developed in this study is sensitive, specific, simple, and cost-effective, enabling rapid detection and biovar differentiation of C. pseudotuberculosis. It is suitable for large-scale clinical sample screening and provides an efficient technical approach for epidemiological monitoring and precise control of the disease.

22 July 2026 in Animals
Verified
Journal Article
Open access
PDF file
YLYusheng Lin
Yusheng Lin
JJJinxiu Jiang
Jinxiu Jiang
WLWeiwei Liu
Weiwei Liu
KRKul Raj Rai
Kul Raj Rai
YCYong-Liang Che
Yong-Liang Che
Orf virus (ORFV) is a major pathogen in goats and sheep, and control currently depends mainly on commercial live vaccines. Although mRNA vaccines have revolutionized human medicine, their use in veterinary settings is largely unexplored. In this study, an mRNA vaccine candidate encoding the ORFV F1L protein (F1L-mRNA-LNP) was developed via in vitro transcription and encapsulated in lipid nanoparticles. BALB/c mice were divided into five groups (n = 14 each): three receiving different doses of F1L-mRNA-LNP (5, 10, or 15 μg), one receiving a commercial live vaccine (CV), and a PBS control group. Mice were immunized intramuscularly and boosted after 14 days; immune responses were assessed 14 days later following ARRIVE 2.0 guidelines. Both the F1L-mRNA-LNP and CV vaccines induced specific antibodies versus PBS (p < 0.01). The 10 μg mRNA group showed Th1 cytokine and CD8+ T cell responses comparable to CV (p > 0.05), whereas IL-4 (Th2) was significantly higher in the CV group (p < 0.05). Neutralizing antibody titers did not differ between groups, indicating that the mRNA vaccine induces comparable Th1 cellular immunity but weaker Th2 humoral immunity. Upon ORFV challenge, the 10 μg F1L-mRNA-LNP vaccine protected BALB/c mice, as evidenced by stable body weight, no clinical symptoms, and reduced viral load, with efficacy comparable to CV (p > 0.05). This study provides strong evidence supporting the optimization of ORFV mRNA vaccines and highlights the translational potential of the F1L-mRNA-LNP candidate vaccine for veterinary applications.